Back
Galectin Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
GALT
Sponsored
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.
Sell
40
GALT
Galectin Therapeutics
Last Price:
2.75
Seasonality Move:
14%
7 Day Trial
ALL ACCESS PASS
$
7
"This Changes Everything" - Trump Hands Millions Massive IRS Gift
Learn More HereGalectin Therapeutics Price Quote
$2.75
+0.06 (+2.23%)
(Updated: November 19, 2024 at 5:55 PM ET)
Galectin Therapeutics Key Stats
Sell
40
Galectin Therapeutics (GALT)
is a Sell
Day range:
$2.65 - $2.85
52-week range:
$1.56 - $4.27
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
0%
Volume:
174K
Avg. volume:
140.3K
1-year change:
37.24%
Market cap:
$168.8M
Revenue:
$0
EPS:
$-0.73
How Much Does Galectin Therapeutics Make?
Data Unavailable
Is Galectin Therapeutics Growing As A Company?
Data Unavailable
Galectin Therapeutics Stock Price Performance
-
Did Galectin Therapeutics Stock Go Up Last Month?
Galectin Therapeutics share price went up by 0.75% last month -
Did GALT's Share Price Rise Over The Last Year?
GALT share price rose by 37.24% over the past 1 year
What Is Galectin Therapeutics 52-Week High & Low?
-
What Is Galectin Therapeutics’s 52-Week High Share Price?
Galectin Therapeutics has traded as high as $4.27 over the past 52 weeks -
What Is Galectin Therapeutics’s 52-Week Low Share Price?
Galectin Therapeutics has traded as low as $1.56 over the past 52 weeks
Galectin Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Galectin Therapeutics?
-
How Much Debt Does Galectin Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Galectin Therapeutics Have?
Cash and short term investments quarterly total is $27.1M -
What Is Galectin Therapeutics’s Book Value Per Share?
Book value per share is -1.52
Is Galectin Therapeutics Cash Flow Positive?
-
What Is GALT Cash Flow From Operations?
Cash flow from operations (TTM) is -$33.7M -
What Is Galectin Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $40.4M -
What Is Galectin Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $0
Galectin Therapeutics Return On Invested Capital
Data Unavailable
Galectin Therapeutics Earnings Date & Stock Price
-
What Is Galectin Therapeutics's Stock Price Today?
A single share of GALT can be purchased today for 2.69 -
What Is Galectin Therapeutics’s Stock Symbol?
Galectin Therapeutics trades on the nasdaq under the ticker symbol: GALT -
When Is Galectin Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Galectin Therapeutics is scheduled on March 28, 2025 -
When Is GALT's next ex-dividend date?
Galectin Therapeutics's next ex-dividend date is November 20, 2024 -
How To Buy Galectin Therapeutics Stock?
You can buy Galectin Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Galectin Therapeutics Competitors
-
Who Are Galectin Therapeutics's Competitors?
Below is a list of companies who compete with Galectin Therapeutics or are related in some way:
Galectin Therapeutics Dividend Yield
-
What Is GALT Dividend Yield?
Galectin Therapeutics’s dividend yield currently is 0% -
What Is Galectin Therapeutics’s Payout Ratio?
Galectin Therapeutics’s payout ratio is 0% -
When Did Galectin Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 20, 2024 -
What Is Galectin Therapeutics’s Dividend Per Share?
Galectin Therapeutics pays a dividend of $0.00 per share
Galectin Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 0% |
Revenue: | 0% | 0% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 11.00 |
Upside from Last Price: | 308.92% |